Gather talents, be innovative
Let immunotherapy benefit human health
Creating high-tech platform combing immune medicine & new drug development
这里是占位文字
BroadenBio Co., Ltd.
Founded in 2018, focusing on new drug R & D.
Our team - senior scientists and managers in pharmaceutical industry, young people
with passion and dreams.
Our platform – combing new drug development and unique immune technology.
Our culture – innovation, collaboration & sharing.
Technology Platform
More +
Technology Platform
Unique immunology technology platform integrates new drug targets discovery and identification for oncology and autoimmune diseases, in vivo and in vitro immunology function testing, and drug candidate evaluation. Chemical service platform covers the functions of process development and optimization, custom synthesis and new drug registration. These platforms become strong technical guarantee for the new drug R&D in BroadenBio, and also provide high-quality services for our customers.